pharmaceutical investing Deciphera Pharmaceuticals Announces Pricing of Public Offering of Common Stock
pharmaceutical investing EyePoint Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Ovid Therapeutics Announces Pricing of $30 Million of Securities in Concurrent Public Offerings of Common and Preferred Stock
RZOLV Reports Approximately 97.0% Gold Recovery on Complex Copper-Gold Ore Without Pretreatment, Highlighting Potential to Simplify Flowsheets Versus Cyanide
RZOLV Reports Approximately 97.0% Gold Recovery on Complex Copper-Gold Ore Without Pretreatment, Highlighting Potential to Simplify Flowsheets Versus Cyanide
